CNSide Diagnostics

CNSide® is a highly sensitive, cerebrospinal fluid-based, laboratory developed test (LDT) for patients with Leptomeningeal Metastases (LM) from carcinomas and melanomas. The first-in-class CNSide™ CSF assay is performed in a CLIA-registered facility in Houston, Texas at the request of top cancer physicians in the U.S. CNSide™ is a highly sensitive, cerebrospinal fluid-based, laboratory developed t  ...